Matricellular Proteins: New Molecular Targets To Prevent Heart Failure

Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure

(2011) Michael R. Zile et al.   Circulation-Heart Failure

Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice

(2010) Tomohiro Nishioka et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study

(2010) Panagiota Georgiadou et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Role of osteopontin in heart failure associated with aging

(2010) Mahipal Singh et al.   HEART FAILURE REVIEWS

Dynamic Expression of Tenascin-C After Myocardial Ischemia and Reperfusion: Assessment by 125I-Anti-Tenascin-C Antibody Imaging

(2010) J. Taki et al.   JOURNAL OF NUCLEAR MEDICINE

Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart

(2009) William E. Stansfield et al.   ANNALS OF THORACIC SURGERY

The regulation of tenascin expression by tissue microenvironments

(2009) Richard P. Tucker et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Pressure Overload-induced Right Ventricular Failure is Associated with Re-expression of Myocardial Tenascin-C and Elevated Plasma Tenascin-C Levels

(2009) Marleen Hessel et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy

(2009) Melissa Swinnen et al.   CIRCULATION

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

(2009) et al.   CIRCULATION

Pressure Overload–Induced Alterations in Fibrillar Collagen Content and Myocardial Diastolic Function

(2009) Amy D. Bradshaw et al.   CIRCULATION

Osteopontin

(2009) Gudrun Szalay et al.   CIRCULATION RESEARCH

Origin of Cardiac Fibroblasts and the Role of Periostin

(2009) Paige Snider et al.   CIRCULATION RESEARCH

Increased plasma levels of osteopontin are associated with activation of the renin–aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy

(2009) Silvia Del Ry et al.   CYTOKINE

Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy

(2009) Marcus Franz et al.   EUROPEAN JOURNAL OF HEART FAILURE

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

(2009) Stephane Heymans et al.   EUROPEAN JOURNAL OF HEART FAILURE

Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice

(2009) Moh H. Malek et al.   EXPERIMENTAL PHYSIOLOGY

High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation

(2009) Bin Tsukada et al.   HUMAN PATHOLOGY

Incremental Prognostic Values of Serum Tenascin-C Levels With Blood B-type Natriuretic Peptide Testing at Discharge in Patients With Dilated Cardiomyopathy and Decompensated Heart Failure

(2009) Naoki Fujimoto et al.   JOURNAL OF CARDIAC FAILURE

Cardiac extracellular matrix remodeling: Fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC)

(2009) Sarah McCurdy et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction

(2009) Marcin Dobaczewski et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

(2009) Kim Midwood et al.   NATURE MEDICINE

Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53

(2009) H.-J. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Decreased Expression of Thrombospondin-1 in Failing Hearts May Favor Ventricular Remodeling

(2009) M. Batlle et al.   TRANSPLANTATION PROCEEDINGS

The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology

(2009) Russell A. Norris et al.   Journal of Cell Communication and Signaling

The role of thrombospondins in wound healing, ischemia, and the foreign body reaction

(2009) Themis R. Kyriakides et al.   Journal of Cell Communication and Signaling

Thrombospondins in the heart: potential functions in cardiac remodeling

(2009) Mark W. M. Schellings et al.   Journal of Cell Communication and Signaling

Thrombospondins function as regulators of angiogenesis

(2009) Paul Bornstein   Journal of Cell Communication and Signaling

The interaction of Thrombospondins with extracellular matrix proteins

(2009) Kemin Tan et al.   Journal of Cell Communication and Signaling

The role of SPARC in extracellular matrix assembly

(2009) Amy D. Bradshaw   Journal of Cell Communication and Signaling

SPARC functions as an inhibitor of adipogenesis

(2009) Jing Nie et al.   Journal of Cell Communication and Signaling

Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart

(2008) Paige Snider et al.   CIRCULATION RESEARCH

Genetic Manipulation of Periostin Expression in the Heart Does Not Affect Myocyte Content, Cell Cycle Activity, or Cardiac Repair

(2008) Angela Lorts et al.   CIRCULATION RESEARCH

Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart Failure

(2008) Mark Rosenberg et al.   Circulation-Heart Failure

Periostin as a Heterofunctional Regulator of Cardiac Development and Disease

(2008) Simon Conway et al.   CURRENT GENOMICS

Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation

(2008) Kenichiro Ishii et al.   DEVELOPMENTAL BIOLOGY

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure

(2008) Norimichi Koitabashi et al.   EUROPEAN JOURNAL OF HEART FAILURE

Noninvasive Detection of Cardiac Repair After Acute Myocardial Infarction in Rats by 111In Fab Fragment of Monoclonal Antibody Specific for Tenascin-C

(2008) Kenichi Odaka et al.   International Heart Journal

Functions and mechanisms of action of CCN matricellular proteins

(2008) Chih-Chiun Chen et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Periostin is essential for cardiac healingafter acute myocardial infarction

(2008) Masashi Shimazaki et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction

(2008) Mark W.M. Schellings et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices

(2008) Hendrik Milting et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction

(2008) Prasanna Krishnamurthy et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart

(2008) Z. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Osteopontin Expression Is Required for Myofibroblast Differentiation

(2007) Yair Lenga et al.   CIRCULATION RESEARCH